title: Sodium-Glucose Cotransporter 2 Inhibitors and Diabetic Ketoacidosis: A Case Series From Three Academic Institutions.
authors.affiliation: University of North Carolina School of Medicine, Chapel Hill, NC.
authors.forename: Negin
authors.initials: N
authors.lastname: Misaghian-Xanthos
authors.affiliation: Duke University School of Medicine, Durham, NC.
authors.forename: Afreen I
authors.initials: AI
authors.lastname: Shariff
authors.affiliation: Wake Forest School of Medicine, Winston-Salem, NC.
authors.forename: Kavya
authors.initials: K
authors.lastname: Mekala
authors.affiliation: University of North Carolina School of Medicine, Chapel Hill, NC.
authors.forename: Loretta R
authors.initials: LR
authors.lastname: Fearrington
authors.affiliation: Duke University School of Medicine, Durham, NC.
authors.forename: Tracy L
authors.initials: TL
authors.lastname: Setji
authors.affiliation: Wake Forest School of Medicine, Winston-Salem, NC.
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Aloi
authors.affiliation: University of North Carolina School of Medicine, Chapel Hill, NC jbuse@med.unc.edu.
authors.forename: John B
authors.identifier: 0000-0002-9723-3876
authors.initials: JB
authors.lastname: Buse